← Leaderboards
Joseph John Barchi
Basic Sciences
$0
Attributed
$0
Total exposure
0
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
—
By mechanism
—
Top collaborators
No co-investigators on record.
Most similar at Basic Sciences
Same institution · by research overlap
Others in their field
Top investigators on “Glycopeptides”
- Barton F Haynes · Duke University$17,006,847
- Suzanne L. Walker · Harvard Medical School$16,884,231
- Samuel J Danishefsky · Sloan-Kettering Institute For Cancer Res$9,838,522
- Richard D Cummings · University Of Oklahoma Hlth Sciences Ctr$9,637,150
- Dale L Boger · Scripps Research Institute, The$9,548,537
- Radoslav Goldman · Georgetown University$8,698,275
Research focus
GlycopeptidesDesignProteinsPeptidesAnalogSugarCollaborationsPharmaceutical PreparationsNeoplastic CellPlayCancer CellReportingAnabolismTherapeutic AgentsCellsDisaccharidesReceptorPublishingManuscriptsAmino AcidsAnnual ReportsTumor Cell LineUniversitiesJournals
Grant awards (44)
Structure and Functional Consequences of Serine vs. Threonine Mucin-Type O-linked Glycosylation$472,388
ZIA · FY2025 · CA · contact PI
Design of novel antitumor immunotherapies based on tumor-associated glycopeptide antigens$472,388
ZIA · FY2025 · CA · contact PI
Glycopeptide Antigen-bearing Nanoparticles for Passive and Active Antitumor Therapy for Pancreatic Cancer$825,904
ZIA · FY2024 · CA · contact PI
A Glycopeptide from Interstitial Cystitis Patients as a Novel Anticancer Lead$353,958
ZIA · FY2024 · CA · contact PI
Carbohydrate Antigen-bearing Nanoparticles for Antitumor Therapy$712,618
ZIA · FY2023 · CA · contact PI
A Glycopeptide from Interstitial Cystitis Patients as a Novel Anticancer Lead$305,407
ZIA · FY2023 · CA · contact PI
Carbohydrate Antigen-bearing Nanoparticles for Antitumor Therapy$706,429
ZIA · FY2022 · CA · contact PI
A Glycopeptide from Interstitial Cystitis Patients as a Novel Anticancer Lead$302,756
ZIA · FY2022 · CA · contact PI
Carbohydrate Antigen-bearing Nanoparticles for Antitumor Therapy$485,016
ZIA · FY2021 · CA · contact PI
A Glycopeptide from Interstitial Cystitis Patients as a Novel Anticancer Lead$207,864
ZIA · FY2021 · CA · contact PI
Carbohydrate Antigen-bearing Nanoparticles for Antitumor Therapy$684,400
ZIA · FY2020 · CA · contact PI
A Glycopeptide from Interstitial Cystitis Patients as a Novel Anticancer Lead$293,314
ZIA · FY2020 · CA · contact PI
A Glycopeptide from Interstitial Cystitis Patients as a Novel Anticancer Lead$502,821
ZIA · FY2019 · CA · contact PI
Carbohydrate Antigen-bearing Nanoparticles for Antitumor Therapy$502,821
ZIA · FY2019 · CA · contact PI
Carbohydrate Antigen-bearing Nanoparticles for Antitumor Therapy$443,395
ZIA · FY2018 · CA · contact PI
A Glycopeptide from Interstitial Cystitis Patients as a Novel Anticancer Lead$443,395
ZIA · FY2018 · CA · contact PI
A Glycopeptide from Interstitial Cystitis Patients as a Novel Anticancer Lead$708,200
ZIA · FY2016 · CA · contact PI
Carbohydrate Antigen-bearing Nanoparticles for Antitumor Therapy$303,514
ZIA · FY2016 · CA · contact PI
A Glycopeptide from Interstitial Cystitis Patients as a Novel Anticancer Lead$641,257
ZIA · FY2015 · CA · contact PI
Carbohydrate Antigen-bearing Nanoparticles for Antitumor Therapy$274,825
ZIA · FY2015 · CA · contact PI
A Glycopeptide from Interstitial Cystitis Patients as a Novel Anticancer Lead$654,974
ZIA · FY2014 · CA · contact PI
Carbohydrate Antigen-bearing Nanoparticles for Antitumor Therapy$280,702
ZIA · FY2014 · CA · contact PI
A Glycopeptide from Interstitial Cystitis Patients as a Novel Anticancer Lead$576,387
ZIA · FY2013 · CA · contact PI
Carbohydrate Antigen-bearing Nanoparticles for Anti-adhesives and Tumor Vaccines$247,023
ZIA · FY2013 · CA · contact PI
A Glycopeptide from Interstitial Cystitis Patients as a Novel Anticancer Lead$435,660
ZIA · FY2012 · CA · contact PI
Carbohydrate Antigen-bearing Nanoparticles for Anti-adhesives and Tumor Vaccines$435,660
ZIA · FY2012 · CA · contact PI
Carbohydrate Antigen-bearing Nanoparticles for Anti-adhesives and Tumor Vaccines$406,632
ZIA · FY2011 · CA · contact PI
A Glycopeptide from Interstitial Cystitis Patients as a Novel Anticancer Lead$406,632
ZIA · FY2011 · CA · contact PI
Carbohydrate Antigen-bearing Nanoparticles for Anti-adhesives and Tumor Vaccines$388,676
ZIA · FY2010 · CA · contact PI
A Glycopeptide from Interstitial Cystitis Patients as a Novel Anticancer Lead$388,676
ZIA · FY2010 · CA · contact PI
A Glycopeptide from Interstitial Cystitis Patients as a Novel Anticancer Lead$363,877
ZIA · FY2009 · CA · contact PI
Carbohydrate Antigen-bearing Nanoparticles for Anti-adhesives and Tumor Vaccines$363,877
ZIA · FY2009 · CA · contact PI
Carbohydrate Antigen-bearing Nanoparticles for Anti-adhesives and Tumor Vaccines$426,309
Z01 · FY2008 · CA · contact PI
Structural Studies of Drug Agents by Nuclear Magnetic Resonance Spectroscopy$229,551
Z01 · FY2008 · CA · contact PI
NMR Group Project: Preparation and Properties of Novel Multivalent Nanoparticles$406,496
Z01 · FY2007 · CA · contact PI
Structural Studies of Drug Agents by Nuclear Magnetic Resonance Spectroscopy$174,213
Z01 · FY2007 · CA · contact PI
Structural Studies of Drug Agents by Nuclear Magnetic Re$0
Z01 · FY2006 · BC · contact PI
NMR Group Project: Preparation and Properties of Novel M$0
Z01 · FY2006 · BC · contact PI
NMR Group Project: Preparation and Properties of Novel M$0
Z01 · FY2005 · BC
NMR Group Project: Biophysical Studies of Oligonucleotid$0
Z01 · FY2005 · BC
NMR Group Project: Biophysical Studies of Oligonucleotid$0
Z01 · FY2004 · BC
NMR Group Project: Biophysical Studies of Oligonucleotid$0
Z01 · FY2003 · BC
Synthesis /Biology /Conformation Study of Tumor Antigens$0
Z01 · FY2002 · BC
NMR Group Project: Structural Analysis of Conformational$0
Z01 · FY2002 · BC